Molecular biomarkers for the prognosis of breast cancer: role of amino acid metabolism genes

The development of precise molecular biomarkers for breast cancer prognosis holds immense potential to improve treatment outcomes. This study aimed to investigate the role of amino acid metabolism genes as predictive markers for breast cancer prognosis and their association with the immune-tumour mi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of physiology and biochemistry Ročník 81; číslo 2; s. 441 - 457
Hlavní autoři: Zhou, Yudong, Yu, Shibo, Zhu, Lizhe, Wang, Yalong, Duan, Chenglong, Li, Danni, Du, Jinsui, Zhang, Jiaqi, Zhang, Jianing, Ma, Ruichao, He, Jianjun, Ren, Yu, Wang, Bin
Médium: Journal Article
Jazyk:angličtina
Vydáno: Dordrecht Springer Netherlands 01.05.2025
Springer Nature B.V
Témata:
ISSN:1138-7548, 1877-8755, 1877-8755
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:The development of precise molecular biomarkers for breast cancer prognosis holds immense potential to improve treatment outcomes. This study aimed to investigate the role of amino acid metabolism genes as predictive markers for breast cancer prognosis and their association with the immune-tumour microenvironment. By employing advanced machine learning algorithms and bioinformatics analysis techniques, the impact of amino acid metabolism-related genes (AAMRGs) on the immune status and overall survival of patients with breast cancer was examined. An AAMRG-based risk model was established to assess the prognostic significance. Validated risk models (AIMP2, IYD, and QARS1) accurately predicted patient outcomes [1 y: 0.87 (0.96–0.78); 3 y: 0.82 (0.87–0.76); 5 y: 0.80 (0.86–0.75)]. Furthermore, this study revealed evidence suggesting that QARS1 may influence breast cancer cell proliferation through methionine metabolism. This analysis provides valuable insights into the mechanisms of breast cancer, emphasizing the significance of AAMRGs as prognostic biomarkers and potential therapeutic targets for optimizing personalized treatment strategies. Key points The development of precise molecular biomarkers for the prognosis of patients with breast cancer holds immense potential in enhancing the outcomes of breast cancer treatment. This study employed machine learning algorithms and bioinformatics analysis techniques to conduct a comprehensive examination of AAMRGs and their impact on the immune status and overall survival of patients with breast cancer. A risk model predicated on AAMRGs was developed to assess their prognostic significance and could markedly bolster the personalized treatment approach for patients with breast cancer.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1138-7548
1877-8755
1877-8755
DOI:10.1007/s13105-025-01088-5